Evidence map›Paper›PMID 37063823›Full record

ArticleFrontiers in immunology2023

Mario M Müller, Christian Baldauf, Stella Hornischer, Tilman E Klassert, Antony Schneegans, Andrea Behnert, Mathias W Pletz, Stefan Hagel, Hortense Slevogt

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Intracellular survival ofVirulence · 2025
    Review
  5. Revealing potential signaling pathways and hub genes related to monocytes in sepsis survivors and non-survivors based on single-cell RNA-seq and bulk RNA-seq data.Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologica · 2025
    Article
  6. Article
  7. Microbiota and Immunity during Respiratory Infections: Lung and Gut Affair.International journal of molecular sciences · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Mario M MüllerSeptomics Research Center, Jena University Hospital, Jena, Germany.
Christian BaldaufSeptomics Research Center, Jena University Hospital, Jena, Germany.
Stella HornischerSeptomics Research Center, Jena University Hospital, Jena, Germany.
Tilman E KlassertSeptomics Research Center, Jena University Hospital, Jena, Germany.
Antony SchneegansSeptomics Research Center, Jena University Hospital, Jena, Germany.
Andrea BehnertSeptomics Research Center, Jena University Hospital, Jena, Germany.
Mathias W PletzInstitute for Infectious Diseases and Infection Control, Jena University Hospital - Friedrich Schiller University Jena, Jena, Germany.
Stefan HagelInstitute for Infectious Diseases and Infection Control, Jena University Hospital - Friedrich Schiller University Jena, Jena, Germany.
Hortense SlevogtSeptomics Research Center, Jena University Hospital, Jena, Germany.
Jena University Hospital · DEMedizinische Hochschule Hannover · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Exposure of human monocytes to lipopolysaccharide (LPS) or other pathogen-associated molecular pattern (PAMPs) induces a temporary insensitivity to subsequent LPS challenges, a cellular state called endotoxin tolerance (ET), associated with the pathogenesis of sepsis. In this study, we aimed to characterize the cellular state of human monocytes from healthy donors stimulated with

Indexed as

MonocytesStaphylococcus aureusFibrinogenGlycoproteinsHumansLigandsLipopolysaccharidesToll-Like Receptor 2FGL2 protein, humanFibrinogenGlycoproteinsLigandsLipopolysaccharidesToll-Like Receptor 2bacteremiaglycoproteinsmarker of tolerancemembrane proteinsmonocyteproteomicsS. aureustolerance

Identifiers

PMID37063823
PMCPMC10104166
OpenAlexW4362470543

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.